Nutrien Ltd. (NYSE:NTR) Shares Sold by Goehring & Rozencwajg Associates LLC

Goehring & Rozencwajg Associates LLC decreased its stake in Nutrien Ltd. (NYSE:NTR) by 5.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 200,439 shares of the company’s stock after selling 11,858 shares during the period. Nutrien accounts for 1.8% of Goehring & Rozencwajg Associates LLC’s investment portfolio, making the stock its 22nd largest holding. Goehring & Rozencwajg Associates LLC’s holdings in Nutrien were worth $9,004,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently modified their holdings of the stock. Live Oak Private Wealth LLC acquired a new position in Nutrien in the fourth quarter valued at $609,000. Strategic Financial Concepts LLC acquired a new stake in shares of Nutrien during the fourth quarter worth about $210,000. Bleakley Financial Group LLC lifted its holdings in shares of Nutrien by 5.4% in the 4th quarter. Bleakley Financial Group LLC now owns 16,776 shares of the company’s stock valued at $751,000 after purchasing an additional 855 shares during the last quarter. ARGA Investment Management LP boosted its position in shares of Nutrien by 25.7% in the 4th quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company’s stock valued at $270,396,000 after purchasing an additional 1,236,671 shares during the period. Finally, Brown Lisle Cummings Inc. grew its stake in Nutrien by 77.2% during the 4th quarter. Brown Lisle Cummings Inc. now owns 16,618 shares of the company’s stock worth $744,000 after buying an additional 7,240 shares during the last quarter. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Trading Down 0.4 %

Shares of NTR stock opened at $50.32 on Friday. Nutrien Ltd. has a 1-year low of $43.69 and a 1-year high of $60.87. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The business’s fifty day moving average price is $48.66 and its 200 day moving average price is $48.11. The firm has a market capitalization of $24.71 billion, a PE ratio of 33.77, a P/E/G ratio of 1.13 and a beta of 0.81.

Nutrien (NYSE:NTR) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The company had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same period last year, the company earned $0.35 earnings per share. The business’s revenue for the quarter was down 5.0% compared to the same quarter last year. As a group, sell-side analysts forecast that Nutrien Ltd. will post 3.49 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Piper Sandler boosted their price objective on Nutrien from $58.00 to $63.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. TD Securities reduced their price target on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating for the company in a research report on Tuesday, November 12th. UBS Group raised their price objective on shares of Nutrien from $51.00 to $53.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 28th. CIBC restated an “outperformer” rating and issued a $55.00 price objective (down from $60.00) on shares of Nutrien in a research note on Tuesday, December 10th. Finally, Wells Fargo & Company increased their target price on shares of Nutrien from $52.00 to $53.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 28th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $58.94.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.